Valuation: Electromed, Inc.

Market Cap 365M 320M 295M 275M 518M 34.69B 529M 3.55B 1.37B 17.03B 1.37B 1.34B 59.27B P/E 2026 *
36.2x
P/E 2027 * 29.8x
Enterprise Value 365M 320M 295M 275M 518M 34.69B 529M 3.55B 1.37B 17.03B 1.37B 1.34B 59.27B EV / Sales 2026 *
4.96x
EV / Sales 2027 * 4.36x
Free-Float
78.56%
Yield 2026 *
-
Yield 2027 * -
1 day+4.18%
1 week+12.65%
Current month+4.18%
1 month+20.31%
3 months+86.34%
6 months+51.34%
Current year+51.34%
1 week 40.37
Extreme 40.37
44.59
1 month 35.61
Extreme 35.61
44.59
Current year 23.01
Extreme 23.01
44.59
1 year 17.73
Extreme 17.73
44.59
3 years 8.8
Extreme 8.8
44.59
5 years 8.75
Extreme 8.75
44.59
10 years 3.38
Extreme 3.38
44.59
Manager TitleAgeSince
Chief Executive Officer 61 30/06/2023
Director of Finance/CFO 44 13/11/2022
Compliance Officer - 31/08/2023
Director TitleAgeSince
Chairman 69 30/06/2023
Director/Board Member 76 20/11/2014
Director/Board Member 57 14/08/2019
Date Insider Type Main position Quantity % Market Cap.
06-07Fiscal year

Chief Executive Officer

29,100 0.3514%
06-03Fiscal year

Chief Financial Officer

31,003 0.3744%
05-14Fiscal year

Chairman

120,000 1.4501%
Change 5-day change 1-year change 3-year change Capi.($)
+4.18%+12.65%+102.16%+311.48% 365M
+2.39%+4.29%+21.80%-1.61% 191B
+1.18%+0.14%-25.21%+17.68% 143B
+1.70%+2.57%-3.67%-19.28% 137B
+0.89%-3.15%-58.90%-20.39% 64B
+1.69%+2.60%+19.19%-2.48% 52.97B
-1.23%-0.87%-28.09%-32.72% 43.82B
+0.42%+1.34%+10.74%+10.93% 37.67B
+0.82%+2.42%+5.91%+41.87% 37.13B
+1.33%-0.03%-14.60%-20.16% 29.5B
Average +1.34%+3.11%+2.93%+28.53% 73.58B
Weighted average by Cap. +1.41%+3.38%-5.02%-2.47%

Financials

2026 *2027 *
Net sales 73.6M 64.62M 59.48M 55.43M 105M 7B 107M 715M 277M 3.43B 276M 270M 11.95B 83.6M 73.4M 67.56M 62.96M 119M 7.95B 121M 813M 315M 3.9B 314M 307M 13.58B
Net income 10.53M 9.25M 8.51M 7.93M 14.96M 1B 15.26M 102M 39.67M 492M 39.55M 38.69M 1.71B 12.83M 11.27M 10.37M 9.66M 18.23M 1.22B 18.6M 125M 48.33M 599M 48.19M 47.14M 2.08B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
01/07/26 US$44.07 +4.18% 121,702
30/06/26 US$42.30 +0.17% 160,430
29/06/26 US$42.23 +1.86% 97,113
26/06/26 US$41.46 +3.52% 201,127
25/06/26 US$40.05 +2.38% 89,093
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
44.07USD
Average target price
40.33USD
Spread / Average Target
-8.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock